0
You visited us 0 times! Enjoying our articles? Unlock Full Access!
Question

When drugs attach to allosteric sites on enzymes, the shapes of active sites radically are affected so that the substrate molecules cannot recognise the active sites.
  1. True
  2. False

A
True
B
False
Solution
Verified by Toppr

When drugs are attached to allosteric sites, they change the shape of the enzyme and its active site. Because of this, the substrate molecules cannot recognize active sites.
1038806_401007_ans_67f2c9b747c342c8a75ab6efeb0cdf71.PNG

Was this answer helpful?
1
Similar Questions
Q1
When drugs attach to allosteric sites on enzymes, the shapes of active sites radically are affected so that the substrate molecules cannot recognise the active sites.
View Solution
Q2
Assertion : Enzymes have active sites that hold substrate molecule for a chemical reaction
Reason : Drugs compete with natural substrate by attaching covalently to the active site of enzyme
View Solution
Q3
Assertion :Competitive inhibitors compete with the natural substrate for their attachment on the active sites of enzymes. Reason: In competitive inhibition, inhibitor binds to allosteric site of the enzyme.
View Solution
Q4
Drugs compete with the natural substrate for their attachment on the active sites of enzymes. Such drugs are called competitive inhibitors
View Solution
Q5
Is allosteric inhibition only applicable in the lock and key mechanism?
Since the induced fit theory tells that the substrate can actually induce a change in the active site of the enzyme, hence even if the inibitor attaches itself to the enzyme, the substrate can attach to it (by changing the shape of the active site).
View Solution